The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pemetrexed and pembrolizumab in patients (pts) with recurrent and/or metastatic (R/M) salivary gland cancer (SGC): Results from non-adenoid cystic cohort.
 
Katharine Price
Consulting or Advisory Role - PDS Biotechnology
(OPTIONAL) Uncompensated Relationships - InSitu Therapeutics; InSitu Therapeutics
 
Nathan Foster
No Relationships to Disclose
 
Erik Asmus
No Relationships to Disclose
 
Harry Fuentes Bayne
No Relationships to Disclose
 
Casey Fazer-Posorske
No Relationships to Disclose
 
Jordan Meyers
No Relationships to Disclose
 
Alaina Oltmans
No Relationships to Disclose
 
Panos Savvides
No Relationships to Disclose
 
Yujie Zhao
Employment - Mayo Clinic
Research Funding - Alpine Immune Sciences (Inst); AstraZeneca (Inst); Elucida Oncology (Inst); GI Innovation Inc (Inst); Incyte (Inst); Incyte (Inst); Merck (Inst); Mirati Therapeutics (Inst); PDS Biotechnology (Inst); Pfizer (Inst); Seagen (Inst); SparX Biotech; Zai Lab (Inst)
 
Patrick McGarrah
No Relationships to Disclose
 
Anna Cooper
No Relationships to Disclose
 
Binav Baral
No Relationships to Disclose
 
Ashish Chintakuntlawar
No Relationships to Disclose